In vivo targeted delivery of CD40 shRNA to mouse intestinal dendritic cells by oral administration of recombinant Sacchromyces cerevisiae

Gene Therapy

Volumn 21, Issue 7, 2014, Pages 709-714

  Zhang, L ^a   Zhang, T ^a   Wang, L ^a   Shao, S ^a   Chen, Z ^a   Zhang, Z ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; SHORT HAIRPIN RNA; TUMOR NECROSIS FACTOR ALPHA; MICRORNA; MIRN30D MICRORNA, MOUSE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE SILENCING; GENE TARGETING; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SACCHAROMYCES CEREVISIAE; WESTERN BLOTTING; ADMINISTRATION AND DOSAGE; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; C57BL MOUSE; CYTOLOGY; GENE VECTOR; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MICROBIOLOGY; ORAL DRUG ADMINISTRATION;

SACCHAROMYCES CEREVISIAE;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, CD40; DENDRITIC CELLS; FEMALE; GENE SILENCING; GENE TARGETING; GENETIC VECTORS; HEK293 CELLS; HUMANS; INTESTINES; MICE; MICE, INBRED C57BL; MICRORNAS; ORGAN SPECIFICITY; RNA, SMALL INTERFERING; SACCHAROMYCES CEREVISIAE;

EID: 84903879301     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2014.50     Document Type: Article

References (52)

1. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-233
2. Hannon GJ. RNA interference. Nature 2002; 418: 244-251
3. Karimi MH, Ebadi P, Pourfathollah AA, Soheili ZS, Samiee S, Ataee Z, et al. Immune modulation through RNA interference-mediated silencing of CD40 in dendritic cells. Cell Immunol 2009; 259: 74-81
4. Grimm D. Small silencing RNAs: State-of-The-Art. Adv Drug Deliv Rev 2009; 61: 672-703
5. Lois C, Hong EJ, Pease S, Brown EJ, Baltimore D. Germline transmission and tissuespecific expression of transgenes delivered by lentiviral vectors. Science 2002; 295: 868-872
6. Burnett JC, Rossi JJ, Tiemann K. Current progress of siRNA/shRNA therapeutics in clinical trials. Biotechnol J 2011; 6: 1130-1146
7. Silva JM, Li MZ, Chang K, Ge W, Golding MC, Rickles RJ, et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 2005; 37: 1281-1288
8. Paddison PJ, Silva JM, Conklin DS, Schlabach M, Li M, Aruleba S, et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 2004; 428: 427-431
9. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002; 16: 948-958
10. Zeng Y, Wagner EJ, Cullen BR. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol Cell 2002; 9: 1327-1333
11. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245-252
12. Palucka K, Banchereau J. Dendritic cells: A link between innate and adaptive immunity. J Clin Immunol 1999; 19: 12-25
13. Qian C, Qian L, Yu Y, An H, Guo Z, Han Y, et al. Fas signal promotes the immunosuppressive function of regulatory dendritic cells via ERK/β-catenin pathway. J Biol Chem 2013; 288: 27825-27835
14. Fu C, Jiang A. Generation of tolerogenic dendritic cells via the E-cadherin/ β-catenin-signaling pathway. Immunol Res 2010; 46: 72-78
15. Lutgens E, Daemen MJAP. CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 2002; 12: 27-32
16. Ma DY, Clark EA. The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol 2009; 21: 265-272
17. Suzuki M, Zheng X, Zhang X, Ichim TE, Sun H, Kubo N, et al. Inhibition of allergic responses by CD40 gene silencing. Allergy 2009; 64: 387-397
18. Wang Y, Wang YM, Wang Y, Zheng G, Zhang GY, Zhou JJ, et al. DNA vaccine encoding CD40 targeted to dendritic cells in situ prevents the development of Heymann nephritis in rats. Kidney Int 2013; 83: 223-232
19. Zheng X, Suzuki M, Zhang X, Ichim T, Zhu F, Ling H, et al. RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis. Arthritis Res Ther 2010; 12: R13
20. Zheng X, Vladau C, Zhang X, Suzuki M, Ichim TE, Zhang Z-X, et al. A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation. Blood 2009; 113: 2646-2654
21. Suzuki M, Zheng X, Zhang X, Li M, Vladau C, Ichim TE, et al. Novel vaccination for allergy through gene silencing of CD40 using small interfering RNA. J Immunol 2008; 180: 8461-8469
22. Taylor PA, Friedman TM, Korngold R, Noelle RJ, Blazar BR. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood 2002; 99: 4601-4609
23. Ripoll È, Merino A, Goma M, Aran JM, Bolaños N, de Ramon L, et al. CD40 gene silencing reduces the progression of experimental lupus nephritis modulating local milieu and systemic mechanisms. PLoS One 2013; 8: E65068
24. Stubbs AC, Martin KS, Coeshott C, Skaates SV, Kuritzkes DR, Bellgrau D, et al. Whole recombinant yeast vaccine activates dendritic cells and elicits protective cellmediated immunity. Nat Med 2001; 7: 625-629
25. Haller AA, Lauer GM, King TH, Kemmler C, Fiolkoski V, Lu Y, et al. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins. Vaccine 2007; 25: 1452-1463
26. Wansley EK, Chakraborty M, Hance KW, Bernstein MB, Boehm AL, Guo Z, et al. Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responses. Clin Cancer Res 2008; 14: 4316-4325
27. Bernstein MB, Chakraborty M, Wansley EK, Guo Z, Franzusoff A, Mostböck S, et al. Recombinant Saccharomyces cerevisiae (yeast-CEA) as a potent activator of murine dendritic cells. Vaccine 2008; 26: 509-521
28. Blanquet S, Meunier JP, Minekus M, Marol-Bonnin S, Alric M. Recombinant Saccharomyces cerevisiae expressing P450 in artificial digestive systems: A model for biodetoxication in the human digestive environment. Appl Environ Microbiol 2003; 69: 2884-2892
29. Vassaux G, Nitcheu J, Jezzard S, Lemoine NR. Bacterial gene therapy strategies. J Pathol 2006; 208: 290-298
30. Yamamoto M, Curiel DT. Cancer gene therapy. Technol Cancer Res Treat 2005; 4: 315-330
31. Lundstrom K. Latest development in viral vectors for gene therapy. Trends Biotechnol 2003; 21: 117-122
32. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003; 4: 346-358
33. Drouault S, Corthier G, Ehrlich SD, Renault P. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl Environ Microbiol 1999; 65: 4881-4886
34. Blanquet S, Marol-Bonnin S, Beyssac E, Pompon D, Renaud M, Alric M. The 'biodrug' concept: An innovative approach to therapy. Trends Biotechnol 2001; 19: 393-400
35. Walch B, Breinig T, Schmitt MJ, Breinig F. Delivery of functional DNA and messenger RNA to mammalian phagocytic cells by recombinant yeast. Gene Therapy 2012; 19: 237-245
36. Dietel B, Cicha I, Voskens CJ, Verhoeven E, Achenbach S, Garlichs CD. Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells. Atherosclerosis 2013; 230: 92-99
37. Escors D, Lopes L, Lin R, Hiscott J, Akira S, Davis RJ, et al. Targeting dendritic cell signaling to regulate the response to immunization. Blood 2008; 111: 3050-3061
38. Kitagawa M, Mitsui H, Nakamura H, Yoshino S, Miyakawa S, Ochiai N, et al. Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor α and CD40 signals. Arthritis Rheumat 1999; 42: 1917-1926
39. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA. Dendritic cell development and survival require distinct NF-κB subunits. Immunity 2002; 16: 257-270
40. Castiello L, Sabatino M, Jin P, Clayberger C, Marincola FM, Krensky AM, et al. Monocyte-derived DC maturation strategies and related pathways: A transcriptional view. Cancer Immunol Immunother 2011; 60: 457-466
41. Fotin-Mleczek M, Duchardt KM, Lorenz C, Pfeiffer R, Ojkic-Zrna S, Probst J, et al. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity. J Immunother 2011; 34: 1-15
42. Chatzigeorgiou A, Lyberi M, Chatzilymperis G, Nezos A, Kamper E. CD40/CD40L signaling and its implication in health and disease. Biofactors 2009; 35: 474-483
43. Schonbeck U, Libby P. The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 2001; 58: 4-43
44. Bishop GA, Hostager BS. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev 2003; 14: 297-309
45. Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev 2009; 229: 152-172
46. Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann NY Acad Sci 2003; 987: 258-261
47. Liu L, Rich BE, Inobe J, Chen W, Weiner HL. Induction of Th2 cell differentiation in the primary immune response: Dendritic cells isolated from adherent cell culture treated with IL-10 prime naive CD4+ T cells to secrete IL-4. Int Immunol 1998; 10: 1017-1026
48. Mahnke K, Schmitt E, Bonifaz L, Enk AH, Jonuleit H. Immature, but not inactive: The tolerogenic function of immature dendritic cells. Immunol Cell Biol 2002; 80: 477-483
49. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: Which signals induce tolerance or immunity?. Trends Immunol 2002; 23: 445-449
50. Pluvinet R, Pétriz J, Torras J, Herrero-Fresneda I, Cruzado JM, Grinyó JM, et al. RNAimediated silencing of CD40 prevents leukocyte adhesion on CD154-Activated endothelial cells. Blood 2004; 104: 3642-3646
51. Gietz, RD Woods, R. Yeast transformation by the LiAc/SS carrier DNA/PEG method. Xiao W (ed). Yeast Protocol. Vol. 313. Totowa, NJ: Humana Press, 2006. pp 107-120
52. Kiflmariam MG, Yang H, Zhang Z. Gene delivery to dendritic cells by orally administered recombinant Saccharomyces cerevisiae in mice. Vaccine 2013; 31: 1360-1363.